antiviral (Toyama)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameantiviral (Toyama)
Drug Alias Name5,6,7-trimethoxyflavone
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHerpes Simplex Virus Type 1 InfectionsCytomegalovirus InfectionsPoliomyelitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesToyama Medical and Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesToyama Medical and Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsHerpes Simplex Virus Type 1 InfectionsCytomegalovirus InfectionsPoliomyelitis

Other Information

ATC CodeN/A
Related LinksN/A